Exploring causal associations between alcohol and coronary heart disease risk factors: Findings from a mendelian randomization study in the copenhagen general population study

European Heart Journal

Volumn 34, Issue 32, 2013, Pages 2519-2528

  Lawlor, Debbie A ^a   Nordestgaard, Børge G ^b,c   Benn, Marianne ^b,c   Zuccolo, Luisa ^a   Tybjaerg Hansen, Anne ^b,c,d   Davey Smith, George ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c Mental Health Services CPH   (Denmark)

^d Rigshospitalet   (Denmark)

Author keywords

ADH1B; ADH1C genes; Alcohol; Blood pressure; Fibrinogen; Glucose; Lipids

Indexed keywords

ADH1B PROTEIN; ADH1C PROTEIN; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MEMBRANE PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC VARIABILITY; GENOTYPE; HUMAN; INSTRUMENTAL VARIABLE ANALYSIS; ISCHEMIC HEART DISEASE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MENDELIAN RANDOMIZATION ANALYSIS; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE;

ADH1B; ADH1C GENES; ALCOHOL; BLOOD PRESSURE; FIBRINOGEN; GLUCOSE; LIPIDS;

ALCOHOL DEHYDROGENASE; ALCOHOL DRINKING; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; COHORT STUDIES; CORONARY DISEASE; DENMARK; FEMALE; FIBRINOGEN; GENOTYPE; HUMANS; LIPIDS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 84883170439     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/eht081     Document Type: Article

References (46)

1. Corrao G, Rubbiati L, Bagnardi V, Zambon A, Poikolainen K. Alcohol and coronary heart disease: a meta-analysis. Addiction 2000;95:1505-1523.
2. Di Castelnouvo A, Rotondo S, Iacoviello L, Donati MD, de Gaetano G. Meta-analysis of wine and beer consumption in relation to vascular risk. Circulation 2002;105:2836-2844. (Pubitemid 34666095)
3. Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ 2011;342:d671.
4. Collins MA, Neafsey EJ, Mukamal KJ, Gray MO, Parks DA, Das DK, Karthuis R. Alcohol in moderation, cardioprotection, and neuroprotection: epidemiological considerations and mechanistic studies. Alcohol Clin Exp Res 2009;33:206-219.
5. Di Castelnuovo A, Costanzo S, Giuseppe R, de Gaetano G, Iacoviello L. Alcohol consumption and cardiovascular risk: mechanism of action and epidemiologial perspectives. Future Cardiol 2009;5:467-477.
6. Costanzo S, Di Castelnuovo A, Donati MB, Iacoviello I, de Gaetano G. Alcohol consumption and mortality in patients with cardiovascular disease: a meta-analysis. J Am Coll Cardiol 2010;55:1339-1347.
7. Bonnet F, Disse E, Lalle M, Mari A, Hojlund K, Anderwald CH, Balckau B. for the RISC Study Group. Moderate alcohol consumption is associated with improved insulin sensitivity, reduced basal insulin secretion rate and lower fasting glucagon concentration in healthy women. Diabetologia 2012;12:3228-3237.
8. Joosten MM, Beulens JW, Kerstens S, Hendriks HFJ. Moderate alcohol consumption increases insulin sensitivity and ADIPOQ expression in postmenopausal women: a randomised, crossover trial. Diabetologia 2008;51:1375-1381.
9. Brien SE, Ronksley PE, Turner BJ, Mukamal KJ, Ghali WA. Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies. BMJ 2011;342:d636.
10. Xin X, He J, Frontini MG, Motsamai OI, Whelton PK. Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension 2001;38:1112-1117. (Pubitemid 34252815)
11. Davey Smith G, Ebrahim S. 'Mendelian randomisation': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003;32:1-22. (Pubitemid 36503465)
12. Lawlor DA, Harbord RM, Sterne JAC, Timpson NJ, Davey Smith G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 2008;27:1133-1163. (Pubitemid 351395448)
13. Davey Smith G, Lawlor DA, Harbord R, Timpson N, Day INM, Ebrahim S. Clustered environments and randomized genes: a fundamental distinction between conventional and genetic epidemiology. PLoS Med 2008;4:e352.
14. Zakhari S. Overview: how is alcohol metabolized by the body? Alcohol Res Health 2006;29:245-254.
15. Macgregor S, Lind PA, Bucholz KK, Hansell NK, Madden PAF, Richter MM, Montgomery GW, Martin NG, Health AC, Whitfield JB. Associations of ADH and ALDH2 gene variation with self report alcohol reactions, consumption and dependence: an integrated analysis. Hum Mol Genet 2009;18:580-593.
16. Chen L, Davey Smith G, Harbord RM, Lewis SJ. Alcohol intake and blood pressure: a systematic review implementing a Mendelian randomization approach. PLoS Med 2008;5:e52.
17. Kato N, Taheuch F, Tabara Y, Kelly TN, Go MJ, Sim X, Tay WT, Chen C-H, Zhang Y, Yamamoto K, Katsuya T, Yokota M, Kim YJ, Ong RTH, Nabika T, Gu D, Chang L-C, Kokubo Y, Huang W, Ohnaka K, Yamori Y, Nakashima E, Jaquish CE, Lee J-Y, Seielstad M, Isono M, Hixson JE, Chen Y-T, Miki T, Zhang X, Suguyama T, Jeon J-P, Liu JJ, Takayanagi R, Kim SS, Aung T, Sung YJ, Zhou X, Wong TY, Kim B-SS, Aung Tm Sung YJ, Zou Z, Wong TY, Han B-G, Kobayashi S, Ogihara T, Zhu D, Iwai N, Wu J-Y, Teo YY, Tai ES, Cho YS, He J. Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure in east Asians. Nat Genet 2011;43:531-538.
18. Takagi S, Iwai N, Yamauchi R, Kojima S, Yasuno S, Baba T, Terashima M, Tsutsumi Y, Suzuki S, Morii I, Hanal S, Ono K, Baba S, Tomoike H, Kawamura A, Miyazaki S, Nonogi H, Goto Y. Aldehyde dehydrogenase 2 gene is a risk factor for myocardial infarction in Japanese men. Hypertens Res 2002; 25:677-681. (Pubitemid 35153754)
19. Takeuchi F, Isono M, Nabika T, Katsuya T, Sugiyam T, Yamaguchi S, Kobayashi S, Ogihara T, Yamori Y, Fujioika A, Kato N. Confirmation of ALDH2 as a major locus of drinking behaviour and of its variants regulating multiple metabolic phe-notypes in a Japanese population. Circ J 2011;75:911-918.
20. Tolstrup JS, Nordestgaard BG, Rasmussen S, Tybjaerg-Hansen A, Grobaek M. Alcoholism and alcohol drinking habits predicted from alcohol dehydrogenase genes. Pharmacogenomics J 2008;8:220-227. (Pubitemid 351712646)
21. Zuccolo L, Fitz-Simon N, Gray R, Ring SM, Sayal K, Davey Smith G, Lewis SJ. A non-synonymous variant in ADH1B is strongly associated with prenatal alcohol use in a European sample of pregnant women. Hum Mol Genet 2009;18: 4457-4466.
22. Hines LM, Stampfer MJ, Ma J, Gaziano JM, Ridker PM, Hankinson SE, Sacks F, Rimm EB, Hunter DJ. Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction. N Engl J Med 2001;344:549-555. (Pubitemid 32167868)
23. Whitfield JB, O'Brien ME, Nightingale BN, Zhu G, Heath AC, Martin NG. ADH genotype does not modify the effects of alcohol on high density lipoprotein. Alcohol Clin Exp Res 2003;27:509-514. (Pubitemid 36343297)
24. Djousse L, Levy D, Herbert AG, Wilson PW, D'Agostino RB, Cupples LA, Karamohamed S, Ellison RC. Influence of alcohol dehydrogenase 1C polymorphism on the alcohol-cardiovascular disease association (from the Framingham Offspring Study). Am J Cardiol 2005;96:227-232. (Pubitemid 40978580)
25. Younis J, Cooper JA, Miller GJ, Humphries SE, Talmud PJ. Genetic variation in alcohol dehydrogenase 1C and the beneficial effect of alcohol intake on coronary heart disease risk in the Second Northwick Park Heart Study. Atherosclerosis 2005; 180:225-232. (Pubitemid 41072891)
26. Ebrahim S, Lawlor DA, Ben-Shlomo Y, Timpson N, Harbord R, Christensen M, Baban J, Keissling M, Day INM, Gaunt T, Davey Smith G. Alcohol dehydrogenase type 1C (ADL2C) variants, alcohol consumption, HDL-cholesterol and risk of coronary heart disease in women and men: British Women's Heart and Health Study and Caerphilly cohorts. Atherosclerosis 2008;196:227-232.
27. Latella MC, Di Castelnuovo A, de Lorgeril M, Arnout J, Cappucio FP, van Doungen MB, de Gaetano G, Lacoviella L. European Collaborative Group of the IMMIDIET Project. Genetic variation of alcohol dehydrogenase type 1C (ADH1C), alcohol consumption, and metabolic cardiovascular risk factors: results from the IMMIDIET study. Atherosclerosis 2009;207:284-290.
28. Timpson NJ, Harbord R, Davey Smith G, Zacho J, Tybjaerg-Hansen A, Nordestgaard BG. Does greater adiposity increase blood pressure and hypertension risk? Mendelian randomization using the FTO/MC4R genotype. Hypertension 2009;54:84-90.
29. Lawlor DA, Harbord RM, Tybjaerg-Hansen A, Palmer TM, Zacho J, Benn M, Timpson NJ, Davey Smith G, Nordestgaard BG. Using genetic loci to understand the relationship between adiposity and psychological distress: a Mendelian randomization study in the Copenhagen General Population Study of 53, 221 adults. J Intern Med 2011;269:525-537.
30. Sethi AA, Tybjaerg-Hansen A, Andersen RV, Nordestgaard BG. Nanogen microelectronic chip for large-scale genotyping. Clin Chem 2004;50:443-446. (Pubitemid 38156390)
31. Lewontin RC. The interaction of selection and linkage. I. General considerations; heterotic models. Genetics 1964;49:49-67.
32. Pritchard JK, Przeworski M. Linkage disequilibrium in humans: models and data. Am J Hum Genet 2001;69:1-14. (Pubitemid 32614013)
33. Frikke-Schmidt R, Nordestgaard BG, Stene MCA, Sethi AA, Remaley AT, Schnohr P, Grande P, Tybjærg-Hansen A. Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease. JAMA 2008;299:2524-2532. (Pubitemid 351787208)
34. Johannsen TH, Kamstrup PR, Andersen RV, Jensen GB, Sillesen H, Tybjærg-Hansen A, Nordestgaard BG. Hepatic lipase, genetically elevated high-density lipoprotein, and risk of ischemic cardiovascular disease. J Clin Endocrinol Metab 2009;94:1264-1273.
35. Haase CL, Tybjærg-Hansen A, Grande P, Frikke-Schmidt R. Genetically elevated apolipoprotein A-I, high-density lipoprotein cholesterol levels, and risk of ische-mic heart disease. J Clin Endocrinol Metab 2010;95:E500-E510.
36. Haase CL, Tybjærg-Hansen A, Qayyum AA, Schou J, Nordestgaard BG, Frikke-Schmidt R. LCAT, HDL cholesterol and ischemic cardiovascular disease: a Mendelian randomization study of HDL cholesterol in 54, 500 individuals. J Clin Endocrinol Metab 2012;97:E248-E256.
37. Voight BF, Peloso GM, Orho-Melander M, Voight BF, Peloso GM, Orho-Melander M, Frikke-Schmidt R, Barbalic M, Jensen MK, Hindy G, Hólm H, Ding EL, Johnson T, Schunkert H, Samani NJ, Clarke R, Hopewell JC, Thompson JF, Li M, Thorleifsson G, Newton-Cheh C, Musunuru K, Pirruccello JP, Saleheen D, Chen L, Stewart A, Schillert A, Thorsteinsdottir U, Thorgeirsson G, Anand S, Engert JC, Morgan T, Spertus J, Stoll M, Berger K, Martinelli N, Girelli D, McKeown PP, Patterson CC, Epstein SE, Devaney J, Burnett MS, Mooser V, Ripatti S, Surakka I, Nieminen MS, Sinisalo J, Lokki ML, Perola M, Havulinna A, de Faire U, Gigante B, Ingelsson E, Zeller T, Wild P, de Bakker PI, Klungel OH, Maitland-van der Zee AH, Peters BJ, de Boer A, Grobbee DE, Kamphuisen PW, Deneer VH, Elbers CC, Onland-Moret NC, Hofker MH, Wijmenga C, Verschuren WM, Boer JM, van der Schouw YT, Rasheed A, Frossard P, Demissie S, Willer C, Do R, Ordovas JM, Abecasis GR, Boehnke M, Mohlke KL, Daly MJ, Guiducci C, Burtt NP, Surti A, Gonzalez E, Purcell S, Gabriel S, Marrugat J, Peden J, Erdmann J, Diemert P, Willenborg C, König IR, Fischer M, Hengstenberg C, Ziegler A, Buysschaert I, Lambrechts D, Van de Werf F, Fox KA, El Mokhtari NE, Rubin D, Schrezenmeir J, Schreiber S, Schäfer A, Danesh J, Blankenberg S, Roberts R, McPherson R, Watkins H, Hall AS, Overvad K, Rimm E, Boerwinkle E, Tybjaerg-Hansen A, Cupples LA, Reilly MP, Melander O, Mannucci PM, Ardissino D, Siscovick D, Elosua R, Stefansson K, O'Donnell CJ, Salomaa V, Rader DJ, Peltonen L, Schwartz SM, Altshuler D, Kathiresan S. Plasma HDL cholesterol and risk of myocardial infarction: a Mendelian randomisation study. Lancet 2012;380:572-580.
38. Schwartz GG, Olsson AG, Abt M, Ballantyne CM, Barter PJ, Brumm J, Chaitman BR, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJV, Mundl H, Nicholls SJ, Shah PK, Tardif J-C, Wright RS. Effects of Dalcetrapib in patients with a recent acute coronary syndrome. NEJM; doi: 10.1056/ NEJMoa1206797. Published online ahead of print 5 November 2012.
39. Varbo A, Benn M, Tybjærg-Hansen A, Jorgensen AB, Frikke-Schmidt R, Nordestgaard BG. Remnant cholesterol as a causal risk factor for ischaemic heart disease. J Am Coll Cardiol 2013;61:427-436.
40. Jorgensen AB, Frikke-Schmidt R, West AS, Grande P, Nordestgaard BG, Tybjærg-Hansen A. Genetically elevated nonfasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction. Eur Heart J 2013;34:1826-1833.
41. Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factor Collaboration. Triglyceride-mediated pathways and coronary heart disease: collaborative analysis of 101 studies. Lancet 2010;375:1634-1639.
42. Cohen JC, Boerwinkle E, Mosley TH, Hobbs HH. Sequence variation in PCSK9, low LDL, and protection against coronary heart disease. NEJM 2006; 354:1264-1272.
43. Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipo-protein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ 2003;326:1423-1427. (Pubitemid 36776152)
44. Davey Smith G, Harbord R, Milton J, Ebrahim S, Sterne JAC. Does elevated plasma fibrinogen increase the risk of coronary heart disease? Evidence from a meta-analysis of genetic association studies. Atheroscler Thromb Vasc Biol 2005; 25:2228-2233. (Pubitemid 41416326)
45. Keavney B, Danesh J, Parish S, Palmer A, Clark S, Youngman L, Delépine M, Lathrop M, Peto R, Collins R. Fibrinogen and coronary heart disease: test of causality by 'Mendelian randomization'. Int J Epidemiol 2006;35:935-943. (Pubitemid 44540744)
46. Davey Smith G. Use of genetic markers and gene-diet interactions for interrogating population-level causal influences of diet on health. Genes Nutr 2011;6:27-43.